RUTHERFORD, N.J. & LA JOLLA, Calif.–(BUSINESS WIRE)–L?kahi Therapeutics™ initiates GMP manufacturing of LT-100 and advances preparations for the program’s next clinical milestone.
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
